Africa: External Aid Cuts Affecting HIV Treatment Across Africa, Says UN

Africa: WHO Validates Brazil for Eliminating Mother-to-Child Transmission of HIV

The World Health Organization (WHO) has validated Brazil for the elimination of mother-to-child transmission (EMTCT) of HIV, making it the most populous country in the Americas to achieve this historic milestone. This accomplishment reflects Brazil’s long-standing commitment to universal and free access to health services through its Unified Health System (SUS), anchored in a strong…

Read More
Africa Calls for Equitable Access to Long-Acting HIV Innovations At UNAIDS Meeting in Brazil

Africa Calls for Equitable Access to Long-Acting HIV Innovations At UNAIDS Meeting in Brazil

Nairobi — African countries have renewed calls for equitable, affordable, and timely access to long-acting HIV prevention and treatment innovations, warning that scientific breakthroughs alone will not end the epidemic without deliberate action to close access and affordability gaps. The call was made during a high-level UNAIDS meeting in Brazil, where Kenya’s National AIDS and…

Read More
Africa: External Aid Cuts Affecting HIV Treatment Across Africa, Says UN

Africa: World Risks Reversing HIV Progress As Children Continue to Face Treatment Gap

Children and adolescents living with HIV-AIDS continue to be left behind in access to early diagnosis, life-saving treatment and care, as shrinking funding threatens to increase their risks and reverse decades of progress, Unicef warned ahead of World AIDS Day. A recently published Unicef-UNAIDS modelling shows that, if programme coverage falls by half, an additional…

Read More
Africa: External Aid Cuts Affecting HIV Treatment Across Africa, Says UN

Africa: New Injectable HIV Treatment Shows Promise in Africa, Study Finds

Nairobi — A new study conducted across three African countries has found that an injectable HIV treatment–Cabotegravir/Rilpivirine (CAB LA + RPV LA), administered every two months–is safe, well tolerated, and preferred by most patients. The Month-12 results, drawn from study sites in Kenya, Uganda, and South Africa, offer renewed hope for improved treatment adherence, fewer…

Read More